NCT04725890View on ClinicalTrials.gov

Safety and Feasibility of a Novel Endoscopic Intervention for the Treatment of Type II Diabetes

NACompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

February 3, 2021

Primary Completion Date

March 1, 2024

Study Completion Date

December 22, 2024

Conditions
Type 2 Diabetes
Interventions
DEVICE

The DyaMX Device

The DyaMX device is designed to induce duodenal mucosal regeneration using pulsed electric field. The DyaMX procedure is a non-surgical, endoscopic procedure.

Trial Locations (2)

2028

The BMI Clinic, Sydney

VIC 3065

St Vincent's Hospital Melbourne, Fitzroy

Sponsors

Lead Sponsor

Endogenex, Inc.
All Listed Sponsors
lead

Endogenex, Inc.

INDUSTRY